XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Lilly
Common Stock [Member]
Common Stock [Member]
Lilly
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Lilly
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Lilly
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Lilly
Beginning balance at Dec. 31, 2019 $ 131,300   $ 2,918   $ 441,395   $ (314,599)   $ 1,586  
Beginning balance, shares at Dec. 31, 2019     28,882,217              
Exercise of stock options and vesting of restricted stock units 602   $ 13   589          
Exercise of stock options and vesting of restricted stock units, shares     127,205              
Stock-based compensation 2,291       2,291          
Currency translation adjustment (3,107)               (3,107)  
Net loss (16,500)           (16,500)      
Ending balance at Mar. 31, 2020 114,586   $ 2,931   444,275   (331,099)   (1,521)  
Ending balance, shares at Mar. 31, 2020     29,009,422              
Beginning balance at Dec. 31, 2019 131,300   $ 2,918   441,395   (314,599)   1,586  
Beginning balance, shares at Dec. 31, 2019     28,882,217              
Short-swing profit disgorgement 0                  
Currency translation adjustment 3,508                  
Net loss (57,549)                  
Ending balance at Sep. 30, 2020 84,501   $ 2,938   448,617   (372,148)   5,094  
Ending balance, shares at Sep. 30, 2020     29,074,536              
Beginning balance at Mar. 31, 2020 114,586   $ 2,931   444,275   (331,099)   (1,521)  
Beginning balance, shares at Mar. 31, 2020     29,009,422              
Exercise of stock options and vesting of restricted stock units 291   $ 4   287   0   0  
Exercise of stock options and vesting of restricted stock units, shares     37,922              
Stock-based compensation 1,192   $ 0   1,192   0   0  
Currency translation adjustment 2,201   0   0   0   2,201  
Net loss (17,974)   0   0   (17,974)   0  
Ending balance at Jun. 30, 2020 100,296   $ 2,935   445,754   (349,073)   680  
Ending balance, shares at Jun. 30, 2020     29,047,344              
Exercise of stock options and vesting of restricted stock units 22   $ 3   19   0   0  
Exercise of stock options and vesting of restricted stock units, shares     27,192              
Stock-based compensation 2,844   $ 0   2,844   0   0  
Currency translation adjustment 4,414   0   0   0   4,414  
Net loss (23,075)   0   0   (23,075)   0  
Ending balance at Sep. 30, 2020 84,501   $ 2,938   448,617   (372,148)   5,094  
Ending balance, shares at Sep. 30, 2020     29,074,536              
Beginning balance at Dec. 31, 2020 102,263   $ 3,211   490,093   (400,112)   9,071  
Beginning balance, shares at Dec. 31, 2020     31,602,953              
Issuance of common stock 129,403 $ 16,477 $ 610 $ 77 128,793 $ 16,400   $ 0   $ 0
Issuance of common stock, shares     5,575,757 706,834            
Exercise of stock options and vesting of restricted stock units 4,824   $ 42   4,782          
Exercise of stock options and vesting of restricted stock units, shares     386,097              
Repurchase of restricted stock units (285)       (285)          
Stock-based compensation 3,400       3,400          
Currency translation adjustment (9,391)               (9,391)  
Net loss (10,154)           (10,154)      
Ending balance at Mar. 31, 2021 236,537   $ 3,940   643,183   (410,266)   (320)  
Ending balance, shares at Mar. 31, 2021     38,271,641              
Beginning balance at Dec. 31, 2020 102,263   $ 3,211   490,093   (400,112)   9,071  
Beginning balance, shares at Dec. 31, 2020     31,602,953              
Short-swing profit disgorgement (282)                  
Currency translation adjustment (11,307)                  
Net loss (52,395)                  
Ending balance at Sep. 30, 2021 205,769   $ 3,976   656,536   (452,507)   (2,236)  
Ending balance, shares at Sep. 30, 2021     38,605,096              
Beginning balance at Mar. 31, 2021 236,537   $ 3,940   643,183   (410,266)   (320)  
Beginning balance, shares at Mar. 31, 2021     38,271,641              
Exercise of stock options and vesting of restricted stock units 1,904   $ 19   1,885   0   0  
Exercise of stock options and vesting of restricted stock units, shares     172,939              
Stock-based compensation 4,559   $ 0   4,559   0   0  
Currency translation adjustment 3,475   0   0   0   3,475  
Net loss (27,388)   0   0   (27,388)   0  
Ending balance at Jun. 30, 2021 219,087   $ 3,959   649,627   (437,654)   3,155  
Ending balance, shares at Jun. 30, 2021     38,444,580              
Exercise of stock options and vesting of restricted stock units 2,313   $ 17   2,296   0   0  
Exercise of stock options and vesting of restricted stock units, shares     160,516              
Short-swing profit disgorgement 282       282          
Stock-based compensation 4,331   $ 0   4,331   0   0  
Currency translation adjustment (5,391)   0   0   0   (5,391)  
Net loss (14,853)   0   0   (14,853)   0  
Ending balance at Sep. 30, 2021 $ 205,769   $ 3,976   $ 656,536   $ (452,507)   $ (2,236)  
Ending balance, shares at Sep. 30, 2021     38,605,096